Goldman Sachs’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.5M | Buy |
1,540,809
+987,482
| +178% | +$15.8M | ﹤0.01% | 2319 |
|
|
2025
Q4 | $4.26M | Buy |
553,327
+107,657
| +24% | +$849K | ﹤0.01% | 3894 |
|
|
2025
Q3 | $3.28M | Buy |
445,670
+275,459
| +162% | +$1.41M | ﹤0.01% | 4037 |
|
|
2025
Q2 | $681K | Sell |
170,211
-198,107
| -54% | -$721K | ﹤0.01% | 4969 |
|
|
2025
Q1 | $1.17M | Sell |
368,318
-216,228
| -37% | -$1.02M | ﹤0.01% | 4559 |
|
|
2024
Q4 | $3.13M | Buy |
584,546
+208,425
| +55% | +$1.56M | ﹤0.01% | 3915 |
|
|
2024
Q3 | $1.99M | Buy |
+376,121
| New | +$1.35M | ﹤0.01% | 4162 |
|
|
2023
Q4 | – | Sell |
-49,324
| Closed | -$72K | – | 5657 |
|
|
2023
Q3 | $72K | Sell |
49,324
-44,987
| -48% | -$95.1K | ﹤0.01% | 5235 |
|
|
2023
Q2 | $216K | Buy |
+94,311
| New | +$196K | ﹤0.01% | 5153 |
|
|
2022
Q4 | – | Sell |
-17,261
| Closed | -$14K | – | 6019 |
|
|
2022
Q3 | $14K | Sell |
17,261
-22,589
| -57% | -$21.6K | ﹤0.01% | 5997 |
|
|
2022
Q2 | $39K | Sell |
39,850
-30,745
| -44% | -$37.7K | ﹤0.01% | 6075 |
|
|
2022
Q1 | $116K | Sell |
70,595
-35,210
| -33% | -$64.5K | ﹤0.01% | 6058 |
|
|
2021
Q4 | $255K | Buy |
105,805
+80,847
| +324% | +$314K | ﹤0.01% | 5752 |
|
|
2021
Q3 | $121K | Sell |
24,958
-625
| -2% | -$1.85K | ﹤0.01% | 5878 |
|
|
2021
Q2 | $68K | Sell |
25,583
-5,221
| -17% | -$14.4K | ﹤0.01% | 6032 |
|
|
2021
Q1 | $95K | Sell |
30,804
-50,950
| -62% | -$184K | ﹤0.01% | 5856 |
|
|
2020
Q4 | $291K | Sell |
81,754
-21,804
| -21% | -$87.8K | ﹤0.01% | 4905 |
|
|
2020
Q3 | $415K | Sell |
103,558
-10,722
| -9% | -$42.8K | ﹤0.01% | 4577 |
|
|
2020
Q2 | $311K | Buy |
114,280
+2,215
| +2% | +$6.54K | ﹤0.01% | 4608 |
|
|
2020
Q1 | $236K | Buy |
112,065
+4,889
| +5% | +$19.9K | ﹤0.01% | 4626 |
|
|
2019
Q4 | $583K | Buy |
107,176
+47,293
| +79% | +$165K | ﹤0.01% | 4412 |
|
|
2019
Q3 | $180K | Sell |
59,883
-949
| -2% | -$3.98K | ﹤0.01% | 4846 |
|
|
2019
Q2 | $228K | Buy |
60,832
+33,729
| +124% | +$132K | ﹤0.01% | 4735 |
|
|
2019
Q1 | $109K | Sell |
27,103
-12,254
| -31% | -$51.7K | ﹤0.01% | 4915 |
|
|
2018
Q4 | $144K | Buy |
39,357
+344
| +0.9% | +$2.35K | ﹤0.01% | 4921 |
|
|
2018
Q3 | $335K | Sell |
39,013
-38,962
| -50% | -$390K | ﹤0.01% | 4655 |
|
|
2018
Q2 | $856K | Buy |
77,975
+42,770
| +121% | +$477K | ﹤0.01% | 4174 |
|
|
2018
Q1 | $406K | Buy |
35,205
+10,810
| +44% | +$102K | ﹤0.01% | 4608 |
|
|
2017
Q4 | $253K | Buy |
+24,395
| New | +$312K | ﹤0.01% | 5281 |
|
|
2017
Q1 | – | Sell |
-12,110
| Closed | -$173K | – | 6786 |
|
|
2016
Q4 | $173K | Sell |
12,110
-12,580
| -51% | -$191K | ﹤0.01% | 5861 |
|
|
2016
Q3 | $406K | Buy |
24,690
+13,680
| +124% | +$197K | ﹤0.01% | 5231 |
|
|
2016
Q2 | $157K | Sell |
11,010
-15,633
| -59% | -$211K | ﹤0.01% | 5860 |
|
|
2016
Q1 | $386K | Buy |
+26,643
| New | +$382K | ﹤0.01% | 5011 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
